Results 101 to 110 of about 12,775 (197)

Combined treatment with amphotericin-B and granulocyte transfusion from G-CSF-stimulated donors in an aplastic patient with invasive aspergillosis undergoing bone marrow transplantation. [PDF]

, 1997
Granulocyte transfusions from G-CSF stimulated donors were added to standard anti-infective treatment in preparation for and during allogeneic bone marrow transplantation in a young man affected by very severe acute aplastic anemia and invasive ...
Catalano L, Fontana R, PICARDI, MARCO, Rocco S, Rotoli B., SCARPATO, NICOLA   +5 more
core  

Pharmacoeconomic analysis of using empegfilgrastim for the treatment of early and locally advanced HER2+ breast cancer in the Russian Federation

Фармакоэкономика
Objective: to assess budget impact of using empegfilgrastim for the prevention of febrile neutropenia in patients with early and locally advanced human epidermal growth factor receptor 2 positive (HER2+) breast cancer who receive neoadjuvant “docetaxel /
M. V. Zhuravleva, K. A. Kokushkin, E. A. Luchinin, E. V. Luchinina, T. R. Kameneva, E. V. Kuznetsova, V. S. Krysanova, E. V. Makarova, L. G. Zhukova   +8 more
doaj   +1 more source

Comparison of biosimilar filgrastim with a reference product: pharmacokinetics, pharmacodynamics, and safety profiles in healthy volunteers

Drug Design, Development and Therapy, 2018
Chungam Choi,1 Byung Won Yoo,2 Choon Ok Kim,2 Taegon Hong,2 Byung Hak Jin,2 Kwang-Seok Seo,3 Ja Yun Jang,4 Min Soo Park2 1Department of Nuclear Medicine, Severance Hospital, Yonsei University Health System, Seoul, Republic of Korea; 2Department of ...
Choi C, Yoo BW, Kim CO, Hong T, Jin BH, Seo KS, Jang JY, Park MS   +7 more
doaj  

Lenograstim and filgrastim in the febrile neutropenia prophylaxis of hospitalized patients: efficacy and cost of the prophylaxis in a retrospective survey

Journal of Blood Medicine, 2018
Rolando Innocenti,1 Luigi Rigacci,1,2 Umberto Restelli,3,4 Barbara Scappini,1 Giacomo Gianfaldoni,1 Rosa Fanci,1 Francesco Mannelli,1 Francesca Scolari,3 Davide Croce,3,4 Erminio Bonizzoni,5 Tania Perrone,6 Alberto Bosi1 1Hematology Department ...
Innocenti R, Rigacci L, Restelli U, Scappini B, Gianfaldoni G, Fanci R, Mannelli F, Scolari F, Croce D, Bonizzoni E, Perrone T, Bosi A   +11 more
doaj  

Efficacy of the Granulocyte Colony-Stimulating Factor in Sepsis-Associated Immunosuppression: An Open-Label Randomized Controlled Trial. [PDF]

Cureus
Reddy KK, Rao SK, Saroj AK, Srivastava C, Singh TB, Palandurkar KM.   +5 more
europepmc   +1 more source

Comparative efficacy and safety of individual short-acting versus long-acting granulocyte colony-stimulating factors, including biosimilars, for primary prophylaxis of chemotherapy-induced myelosuppression in breast cancer patients: a systematic review and network meta-analysis protocol. [PDF]

Front Oncol
Bi X, Shu S, Tang K, Yin P, Chen Y.
europepmc   +1 more source

An Exploratory Analysis of Pharmaceutical Price Disparities and Their Implications Among Six Developed Nations [PDF]

In our study of 43 drugs, prescription drug prices in several wealthy nations (Australia, Canada, France, Germany, and the U.K.) were much lower than in the U.S. on average, well below relative per capita GDP. There was relatively little difference among
Calfee, John E., DuPr�, Elizabeth, Villarreal, Mario   +2 more
core   +1 more source

Multimodal evaluation of mannose engineered poly lactic glycolic acid nanoparticles with granulocyte colony stimulating factor focused delivery to bone marrow for neutropenia. [PDF]

Sci Rep
Karwasra R, Bano N, Ahmad S, Singh S, Khanna K, Sharma N, Raza K, Verma S.   +7 more
europepmc   +1 more source

Prolonged myopathy and musculoskeletal symptoms following filgrastim in a 43-Year-Old female stem cell donor: a case-based review. [PDF]

Rheumatol Int
Rogowska J, Kakowski R, Makowska J, Brzezińska O.   +3 more
europepmc   +1 more source

Sandoz Inc. v. Amgen Inc.: Removing Barriers to Market Access for Biosimilar Manufacturers [PDF]

, 2019
Koya, Moyosore O.
core   +1 more source